Molecular imaging along the heart-kidney axis.

Area of Science:

• Cardiology
• Nephrology
• Molecular Imaging
• Theranostics

Background:

• Cardiorenal syndrome (CRS) describes the complex interplay between heart and kidney dysfunction.
• Pathophysiological mechanisms include pro-fibrotic signaling, inflammation, nerve issues, and altered renal glucose transport.
• Understanding these interactions is crucial for managing CRS.

Purpose of the Study:

• To explore the role of molecular imaging in understanding cardiorenal syndrome.
• To discuss the application of SPECT and PET agents for analyzing heart-kidney axis interactions.
• To highlight the potential of molecular imaging in prognostication and guiding therapeutic interventions in CRS.

Main Methods:

• Utilizing molecular imaging techniques such as Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET).
• Employing targeted whole-body imaging to analyze systems-based interactions along the heart-kidney axis.
• Investigating specific pathophysiological pathways including fibrosis, inflammation, and renal transporter activity.

Main Results:

• Molecular imaging offers a systems-based approach to analyze the heart-kidney axis in CRS.
• It holds potential for prognostic assessment of organ-based functional decline.
• PET imaging can guide reparative interventions by identifying peak activation, enabling theranostics.

Conclusions:

• Molecular imaging is a valuable tool for investigating the complex mechanisms of cardiorenal syndrome.
• Targeted imaging provides insights into prognostic factors and therapeutic strategies.
• The future of CRS management may involve advanced molecular imaging for theranostic applications.